Method Sign up free

Borrower record · Q2 2026

Superior Biologics

As filed by 2 BDCs · period end 30 June 2026NAICS 62 · Health Care and Social Assistance

Two lenders report $36.3m of Superior Biologics at Q2 2026, marked at par. First-Lien Senior Secured on all two positions whose seniority a filer disclosed.

Filed fair value
$36.3m
2 funded positions
Reporting lenders
2
across 2 filed positions
Aggregate mark
100.0c
cost filed on all 2 positions
Maturities to
2033
one date, 27 May 2033
Periods on record
1
first seen Q2 2026

How this total is counted

Pricing as filed

2 floating tranches · SOFR

500bp on all 2 floating tranches — every filer reports the same spread.

2 tranches carry an index floor of 0.75%.

Capital structure

First-Lien Senior Secured, on all 2 positions whose seniority a filer disclosed.

Rate structure

Floating, on all 2 positions whose interest type a filer disclosed.

Maturity profile

all 2 funded positions dated
2033
$36.3m

6.9 years to maturity, weighted by fair value across the 2 dated positions.

Credit flags

No lender reports this borrower on non-accrual, and no filed tranche pays in kind.

Not in the filings

Sign up for free

Who holds it, and where they mark it.

2 lenders hold the same credit and mark it differently. Behind the gate, one row each — for this borrower and for every other one on this site, free and with no limit on how many you read.

LenderPositionsFair valueMarkSpreadMaturityAccrual

Every filing behind this page

2 filers · Q2 2026
FilerCIKFormPeriodFiledAccession
Stone Point Credit Corp000182538410-Q2026-06-302026-08-140001193125-26-352549
Stone Point Credit Income Fund000203128310-Q2026-06-302026-08-140002031283-26-000012

Related borrowers

Same lenders

Same sector